甲状旁腺功能减退症的诊断与治疗：巴西内分泌与代谢学会的立场声明
Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism.
作者信息
Maeda Sergio Setsuo, Moreira Carolina Aguiar, Borba Victória Zeghbi Cochenski, Bandeira Francisco, Farias Maria Lucia Fleiuss de, Borges João Lindolfo Cunha, Paula Francisco José Albuquerque de, Vanderlei Felipe Augusto Brasileiro, Montenegro Fábio Luiz de Menezes, Santos Rodrigo Oliveira, Ferraz-de-Souza Bruno, Lazaretti-Castro Marise
机构信息
Departamento de Medicina, Disciplina de Endocrinologia, Universidade Federal de São Paulo, São Paulo, SP, Brasil.
Hospital de Clínicas, Universidade Federal do Paraná, Curitiba, PR, Brasil.
出版信息
Arch Endocrinol Metab. 2018 Feb;62(1):106-124. doi: 10.20945/2359-3997000000015.
Abstract
Objective To present an update on the diagnosis and treatment of hypoparathyroidism based on the most recent scientific evidence. Materials and methods The Department of Bone and Mineral Metabolism of the Sociedade Brasileira de Endocrinologia e Metabologia (SBEM; Brazilian Society of Endocrinology and Metabolism) was invited to prepare a document following the rules set by the Guidelines Program of the Associação Médica Brasileira (AMB; Brazilian Medical Association). Relevant papers were retrieved from the databases MEDLINE/PubMed, LILACS, and SciELO, and the evidence derived from each article was classified into recommendation levels according to scientific strength and study type. Conclusion An update on the recent scientific literature addressing hypoparathyroidism is presented to serve as a basis for the diagnosis and treatment of this condition in Brazil.
摘要
目的 根据最新科学证据，介绍甲状旁腺功能减退症的诊断和治疗的最新情况。材料和方法 巴西内分泌与代谢学会（SBEM）骨与矿物质代谢科受邀按照巴西医学协会（AMB）指南项目制定的规则编写一份文件。从MEDLINE/PubMed、LILACS和SciELO数据库中检索相关论文，并根据科学强度和研究类型将每篇文章得出的证据分为推荐级别。结论 介绍了有关甲状旁腺功能减退症的最新科学文献的最新情况，作为巴西对该病症进行诊断和治疗的依据。
相似文献
1
Diagnosis and treatment of hypoparathyroidism: a position statement from the Brazilian Society of Endocrinology and Metabolism.甲状旁腺功能减退症的诊断与治疗：巴西内分泌与代谢学会的立场声明
Arch Endocrinol Metab. 2018 Feb;62(1):106-124. doi: 10.20945/2359-3997000000015.
2
Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D.巴西内分泌与代谢学会（SBEM）关于维生素D缺乏症诊断与治疗的建议
Arq Bras Endocrinol Metabol. 2014 Jul;58(5):411-33. doi: 10.1590/0004-2730000003388.
3
The II Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19 Joint Guidelines of the Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia and Sociedade Brasileira de Reumatologia.《巴西第二版 COVID-19 住院患者药物治疗指南》联合指南：巴西急诊医学协会、巴西重症监护医学协会、巴西医师协会、巴西血管和血管外科学会、巴西传染病学会、巴西肺病学会和结核病学会以及巴西风湿病学会。
Crit Care Sci. 2023 Dec 22;35(3):243-255. doi: 10.5935/2965-2774.20230136-en. eCollection 2023.
4
Brazilian Guidelines for the pharmacological treatment of patients hospitalized with COVID-19: Joint guideline of Associação Brasileira de Medicina de Emergência, Associação de Medicina Intensiva Brasileira, Associação Médica Brasileira, Sociedade Brasileira de Angiologia e Cirurgia Vascular, Sociedade Brasileira de Infectologia, Sociedade Brasileira de Pneumologia e Tisiologia, Sociedade Brasileira de Reumatologia.巴西 COVID-19 住院患者药物治疗指南：巴西急诊医学协会、巴西重症监护医学协会、巴西医学协会、巴西血管和血管外科学会、巴西传染病学会、巴西肺病和结核病学会、巴西风湿病学会联合指南。
Rev Bras Ter Intensiva. 2022 Jan-Mar;34(1):1-12. doi: 10.5935/0103-507X.20220001-pt.
5
Diagnosis and management of Paget's disease of bone.骨佩吉特病的诊断与管理
Arq Bras Endocrinol Metabol. 2014 Aug;58(6):587-99. doi: 10.1590/0004-2730000002941.
6
Diagnosis and management of primary hyperparathyroidism--a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism.原发性甲状旁腺功能亢进症的诊断与管理——巴西内分泌与代谢学会骨代谢部的科学声明
Arq Bras Endocrinol Metabol. 2013 Aug;57(6):406-24. doi: 10.1590/s0004-27302013000600002.
7
Approach to adult patients with primary hypothyroidism in some special situations: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).成人原发性甲状腺功能减退症某些特殊情况下的处理方法：巴西内分泌学会甲状腺分会的立场声明。
Arch Endocrinol Metab. 2022 Nov 17;66(6):871-882. doi: 10.20945/2359-3997000000545.
8
References from Brazilian medical journals in national publications.巴西医学期刊在国内出版物中的参考文献。
Rev Assoc Med Bras (1992). 2013 Nov-Dec;59(6):571-5. doi: 10.1016/j.ramb.2013.06.012. Epub 2013 Nov 8.
9
A review of cardiopulmonary research in Brazilian medical journals: clinical, surgical and epidemiological data.巴西医学期刊中心血管肺脏研究综述：临床、外科和流行病学数据。
Clinics (Sao Paulo). 2010 Apr;65(4):441-5. doi: 10.1590/S1807-59322010000400014.
10
Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.甲状腺髓样癌的诊断、治疗及随访：巴西内分泌与代谢学会甲状腺科的建议
Arq Bras Endocrinol Metabol. 2014 Oct;58(7):667-700. doi: 10.1590/0004-2730000003427.
引用本文的文献
1
The predictive value of postoperative intact parathyroid hormone for symptomatic hypocalcemia in older patients with thyroid cancer.术后完整甲状旁腺激素对老年甲状腺癌患者症状性低钙血症的预测价值。
Gland Surg. 2025 Mar 31;14(3):510-519. doi: 10.21037/gs-2024-526. Epub 2025 Mar 26.
2
Management of autosomal dominant hypocalcemia type 1: Literature review and clinical practice recommendations.1型常染色体显性低钙血症的管理：文献综述与临床实践建议
J Endocrinol Invest. 2025 Apr;48(4):831-844. doi: 10.1007/s40618-024-02496-y. Epub 2024 Nov 28.
3
Coronary calcium score in patients with post-surgical hypoparathyroidism.术后甲状旁腺功能减退症患者的冠状动脉钙评分。
Arch Endocrinol Metab. 2024 Apr 4;68:e230053. doi: 10.20945/2359-4292-2023-0053.
4
Treatment options in hypoparathyroidism.甲状旁腺功能减退症的治疗选择。
Arch Endocrinol Metab. 2022 Nov 11;66(5):651-657. doi: 10.20945/2359-3997000000554.
5
Skeletal and nonskeletal consequences of hypoparathyroidism.甲状旁腺功能减退症的骨骼和非骨骼后果。
Arch Endocrinol Metab. 2022 Nov 11;66(5):642-650. doi: 10.20945/2359-3997000000553.
6
Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies.意大利地中海贫血和血红蛋白病协会（SITE）关于血红蛋白病患者内分泌并发症管理的良好临床实践。
J Clin Med. 2022 Mar 25;11(7):1826. doi: 10.3390/jcm11071826.
7
[Review of clinical practice guidelines for hypoparathyroidism].[甲状旁腺功能减退症临床实践指南综述]
Probl Endokrinol (Mosk). 2021 Aug 17;67(4):68-83. doi: 10.14341/probl12800.
8
Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report.慢性甲状旁腺功能减退症中持续特立帕肽治疗：病例报告。
Am J Case Rep. 2021 Aug 14;22:e931739. doi: 10.12659/AJCR.931739.
9
Hipopara-Red, Real Life Experience in 322 Patients With Hypoparathyroidism.低甲状旁腺功能减退症患者的真实生活体验：322例患者的研究
J Endocr Soc. 2020 Nov 28;5(2):bvaa181. doi: 10.1210/jendso/bvaa181. eCollection 2021 Feb 1.
10
Skeletal abnormalities in Hypoparathyroidism and in Primary Hyperparathyroidism.甲状旁腺功能减退症和原发性甲状旁腺功能亢进症的骨骼异常。
Rev Endocr Metab Disord. 2021 Dec;22(4):789-802. doi: 10.1007/s11154-020-09614-0. Epub 2020 Nov 16.
本文引用的文献
1
Hypoparathyroidism and pseudohypoparathyroidism: etiology, laboratory features and complications.甲状旁腺功能减退症和假性甲状旁腺功能减退症：病因、实验室检查特征及并发症
Arch Endocrinol Metab. 2016 Nov-Dec;60(6):532-536. doi: 10.1590/2359-3997000000221. Epub 2016 Nov 24.
2
Intraoperative localization of the parathyroid glands with indocyanine green and Firefly(R) technology during BABA robotic thyroidectomy.在BABA机器人甲状腺切除术中使用吲哚菁绿和萤火虫（Firefly）技术对甲状旁腺进行术中定位。
Surg Endosc. 2017 Jul;31(7):3020-3027. doi: 10.1007/s00464-016-5330-y. Epub 2016 Nov 18.
3
Enhanced identification and functional protective role of carbon nanoparticles on parathyroid in thyroid cancer surgery: A retrospective Chinese population study.碳纳米颗粒在甲状腺癌手术中对甲状旁腺的增强识别及功能保护作用：一项中国人群回顾性研究
Medicine (Baltimore). 2016 Nov;95(46):e5148. doi: 10.1097/MD.0000000000005148.
4
Vertebral Fractures and Bone Mineral Density in Patients With Idiopathic Hypoparathyroidism on Long-Term Follow-Up.特发性甲状旁腺功能减退症患者长期随访中的椎体骨折与骨矿物质密度
J Clin Endocrinol Metab. 2017 Jan 1;102(1):251-258. doi: 10.1210/jc.2016-3292.
5
Potential role of carbon nanoparticles in protection of parathyroid glands in patients with papillary thyroid cancer.碳纳米颗粒在甲状腺乳头状癌患者甲状旁腺保护中的潜在作用。
Medicine (Baltimore). 2016 Oct;95(42):e5002. doi: 10.1097/MD.0000000000005002.
6
Epidemiology and Health-Related Quality of Life in Hypoparathyroidism in Norway.挪威甲状旁腺功能减退症的流行病学及与健康相关的生活质量
J Clin Endocrinol Metab. 2016 Aug;101(8):3045-53. doi: 10.1210/jc.2016-1477. Epub 2016 May 17.
7
Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.甲状旁腺激素（1-84）治疗甲状旁腺功能减退症：一项为期六年的疗效与安全性前瞻性研究。
J Clin Endocrinol Metab. 2016 Jul;101(7):2742-50. doi: 10.1210/jc.2015-4135. Epub 2016 May 4.
8
The feasibility of indocyanine green fluorescence imaging for identifying and assessing the perfusion of parathyroid glands during total thyroidectomy.吲哚菁绿荧光成像在全甲状腺切除术中识别和评估甲状旁腺灌注的可行性。
J Surg Oncol. 2016 Jun;113(7):775-8. doi: 10.1002/jso.24237. Epub 2016 Apr 4.
9
Allotransplantation of macroencapsulated parathyroid cells as a treatment of severe postsurgical hypoparathyroidism: case report.大包裹甲状旁腺细胞同种异体移植治疗严重术后甲状旁腺功能减退：病例报告
Ann Saudi Med. 2016 Mar-Apr;36(2):143-7. doi: 10.5144/0256-4947.2016.21.3.1130. Epub 2016 Mar 21.
10
Refractory Hypoparathyroidism in a Child with Celiac Disease.一名患有乳糜泻儿童的难治性甲状旁腺功能减退症
Isr Med Assoc J. 2016 Jan;18(1):58-60.
Zotero 插件